Amanote Research
Register
Sign In
Erratum: A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss
Obesity
- United States
doi 10.1002/oby.22445
Full Text
Open PDF
Abstract
Available in
full text
Categories
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
Date
February 12, 2019
Authors
Unknown
Publisher
Wiley
Related search
Erratum: A Randomized, Double‐Blind, Placebo‐Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss
Obesity
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
Effects of Oral Methamphetamine on Cocaine Use: A Randomized, Double-Blind, Placebo-Controlled Trial
Drug and Alcohol Dependence
Psychiatry
Toxicology
Mental Health
Pharmacology
A Randomized Double-Blind Placebo Controlled Trial of Oral Acyclovir in Renal Allograft Recipients
Canadian Journal of Infectious Diseases
ADHD and EEG-neurofeedback: A Double-Blind Randomized Placebo-Controlled Feasibility Study
Journal of Neural Transmission
Psychiatry
Mental Health
Neurology
Biological Psychiatry
IQP-GC-101 Reduces Body Weight and Body Fat Mass: A Randomized, Double-Blind, Placebo-Controlled Study
Phytotherapy Research
Pharmacology
A Randomized, Placebo-Controlled, Double-Blind Trial of Sertraline for Postpartum Depression
Psychopharmacology
Pharmacology
A Randomized, Double-Blind, Placebo-Controlled Study of Oral Antioxidant Supplement Therapy in Patients With Dry Eye Syndrome
Clinical Ophthalmology
Ophthalmology
Eptinezumab in Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study (PROMISE-1)
Cephalalgia
Medicine
Neurology
Mp75-01 Paravertebral Block for Percutaneous Nephrolithotomy: A Prospective, Randomized, Double-Blind Placebo-Controlled Study
Journal of Urology
Urology
